Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group-Reference-Cited by-同舟云学术

Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group

Published:2020 Issue:11 Volume:60 Page:543-552
ISSN:0470-8105
Container-title:Neurologia medico-chirurgica
language:en
Short-container-title:Neurol. Med. Chir.(Tokyo)

Author:

ONO Takahiro¹,SASAJIMA Toshio¹,SHIMIZU Hiroaki¹,NATSUMEDA Manabu²,KANAMORI Masayuki³,ASANO Kenichiro⁴,BEPPU Takaaki⁵,MATSUDA Kenichiro⁶,ICHIKAWA Masahiro⁷,FUJII Yukihiko²,OHKUMA Hiroki⁴,OGASAWARA Kuniaki⁵,SONODA Yukihiko⁶,SAITO Kiyoshi⁷,NOBUSAWA Sumihito⁸,NAKAZATO Yoichi⁹,KITANAKA Chifumi¹⁰,KAYAMA Takamasa¹¹,TOMINAGA Teiji³,

Affiliation:

1. Department of Neurosurgery, Akita University Graduate School of Medicine

2. Department of Neurosurgery, Brain Research Institute, Niigata University

3. Department of Neurosurgery, Tohoku University Graduate School of Medicine

4. Department of Neurosurgery, Hirosaki University Graduate School of Medicine

5. Department of Neurosurgery, Iwate Medical University

6. Department of Neurosurgery, Faculty of Medicine, Yamagata University

7. Department of Neurosurgery, Fukushima Medical University

8. Department of Human Pathology, Gunma University Graduate School of Medicine

9. Department of Pathology, Hidaka Hospital

10. Department of Molecular Cancer Science, Yamagata University School of Medicine

11. Department of Advanced Medicine, Faculty of Medicine, Yamagata University

Publisher

Japan Neurosurgical Society

Subject

Clinical Neurology,Surgery

Link

https://www.jstage.jst.go.jp/article/nmc/60/11/60_oa.2020-0155/_pdf

Reference27 articles.

1. 1) Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Eds): World Health Organization classification of tumours of the central nervous system revised 4th, Lyon: International Agency for Research on Cancer, 2016

2. 2) Giannini C, Scheithauer BW, Burger PC, et al.: Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 85: 2033–2045, 1999

3. 3) Korshunov A, Chavez L, Sharma T, et al.: Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis. Brain Pathol 28: 656–662, 2017

4. 4) Ida CM, Rodriguez FJ, Burger PC, et al.: Pleomorphic xanthoastrocytoma: natural history and long-term follow-up. Brain Pathol 25: 575–586, 2015

5. 5) Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR: Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 26: 479–485, 2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring prognostic factors and treatment strategies for long-term survival in pleomorphic xanthoastrocytoma patients;Scientific Reports;2024-02-26

2. Diffusely Infiltrating Gliomas With Poor Prognosis, TERT Promotor Mutations, and Histological Anaplastic Pleomorphic Xanthoastrocytoma-Like Appearance Classify as Mesenchymal Type of Glioblastoma, IDH-wildtype by Methylation Analysis;NEUROSURG PRACT;2023

3. Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation;World Neurosurgery;2022-08

4. GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma;Frontiers in Oncology;2022-03-18

5. Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas;Journal of Neuro-Oncology;2021-05-10